Medycyna Paliatywna

Abstract

4/2022 vol. 14
Guidelines/recommendations

Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer

  1. Klinika Medycyny Paliatywnej, Katedra Onkologii, Uniwersytet Medyczny, Łódź, Polska
  2. Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej, Centralny Szpital Weteranów, Łódź, Polska
Medycyna Paliatywna 2022; 14(4): 183–188
Online publish date: 2023/05/02
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Venous thromboembolism occurring in the form of thrombosis or pulmonary embolism is an interdisciplinary problem of modern medicine. It is the third most common acute cardiovascular disease after myocardial infarction and stroke. Its incidence and risk of occurrence increase with age and the presence of multimorbidity and reduction in the patient’s functional capacity. Given the above, the patient receiving palliative care appears to be at particular risk of developing venous thromboembolism, and the physician caring for them should have clear guidelines for prevention. The first part of this paper presents an analysis of the available literature on assessing risk factors and the incidence of venous thromboembolism.
Share
without publication fees
without publication fees